Emerging Therapies For Newly Diagnosed Or Relapsed AML Patients

Emerging Therapies For Newly Diagnosed Or Relapsed AML Patients

obr

1 year
57 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Keith Pratz, MD Assistant Professor of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, discusses Emerging Therapies For Newly Diagnosed Or Relapsed AML Patients. At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com
Up Next Autoplay